Diagnosis and treatment of dementia: Introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia
- 26 November 2007
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 178 (3), 316-321
- https://doi.org/10.1503/cmaj.070795
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseNature Genetics, 2007
- Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Nature, 2006
- A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17Brain, 2006
- Memantine for dementiaPublished by Wiley ,2005
- A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline ResultsNeuroepidemiology, 2003
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseThe New England Journal of Medicine, 2002
- The Recognition, Assessment and Management of Dementing Disorders: Conclusions from the Canadian Consensus Conference on DementiaCanadian Journal of Neurological Sciences, 2001
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- The Canadian Study of Health and Aging *Neurology, 1994
- Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations A report by the Canadian task force on the periodic health examinationJournal of Clinical Epidemiology, 1990